Find it in your heart
Leila Kia, Mary F. Mulcahy, Josh Levitsky – 27 February 2013
Role of microdialysis catheters in clinical decision making: Bench to bedside?
Michael Ramsay – 27 February 2013
Moving toward evidence‐based liver allocation in patients with primary sclerosing cholangitis
Russell H. Wiesner – 27 February 2013
Fast‐tracking and fairness: Getting organ offers quickly to candidates who will accept them
Sommer E. Gentry, Dorry L. Segev – 27 February 2013
Offer patterns of nationally placed livers by donation service area
Jennifer C. Lai, Sandy Feng, Eric Vittinghoff, John P. Roberts – 27 February 2013 – We previously reported that national liver distribution is highly concentrated in 6 US centers, and this raises the possibility of expedited placement. Therefore, we evaluated all national offers of nationally placed livers (n=1625) to adult wait‐list candidates from February 2005 to January 2010. We developed a model to predict national utilization pathways; pathways exceeding the best‐fit linear unbiased predictions by ≥3 standard errors were defined as preferred.
Liver transplantation in a patient with Ehlers‐Danlos syndrome
Humberto E. Bohorquez, Daniel Gomez, Ari J. Cohen, David S. Bruce, Ian C. Carmody, Trevor W. Reichman, George E. Loss – 27 February 2013
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation
Lewis W. Teperman, Fred Poordad, Natalie Bzowej, Paul Martin, Surakit Pungpapong, Thomas Schiano, John Flaherty, Phillip Dinh, Stephen Rossi, G. Mani Subramanian, James Spivey – 27 February 2013 – Long‐term prophylaxis with hepatitis B immunoglobulin (HBIG) for the prevention of hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) in patients with chronic HBV infection is inconvenient and costly.
Technical aspects and outcomes of living donor liver transplantation for pediatric patients with situs inversus
Rodrigo Vincenzi, Joao Seda‐Neto, Eduardo Antunes da Fonseca, Bernardo Mazzini Ketzer, Marcel Benavides, Helry Lopes Cândido, Gilda Porta, Irene Kazue Miura, Renata Pugliese, Vera Baggio Danesi, Teresa Cristina Guimaraes, Adriana Porta, Cristian Barbieri Borges, Mario Kondo, Paulo Chapchap – 27 February 2013 – The vascular anomalies encountered in patients with biliary atresia associated with polysplenia syndrome and situs inversus (SI) demand technical refinements when liver transplantation is being performed.
Erythrocytosis after liver transplantation: The experience of a university hospital
Gabriella Cordone, Fabiana Zingone, Giuseppe Cardillo, Vincenzo Martinelli, Novella Pugliese, Lucienne Pellegrini, Carolina Ciacci, Gianpaolo Parrilli – 27 February 2013 – The prevalence and causes of erythrocytosis after liver transplantation have never been studied, even though this condition is known to predispose patients to thrombosis leading to graft failure or death. Erythrocytosis after orthotopic liver transplantation (OLT) can be defined as an increase in the red cell mass >125% in patients without a pre‐OLT history of this condition.
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen–positive liver transplant candidates
Edward J. Gane, Scott Patterson, Simone I. Strasser, Geoffrey W. McCaughan, Peter W. Angus – 27 February 2013 – Without effective prophylaxis, liver transplantation for hepatitis B virus (HBV)–related liver disease is frequently complicated by severe and rapidly progressive HBV recurrence. Combination prophylaxis with hepatitis B immune globulin (HBIG) and lamivudine (LAM) reduces long‐term recurrence rates below 10%; however, HBIG is costly and inconvenient to administer.